bpc-157 degenerative disc disease BPC-157: Herniation & Lower Back Pain: Canadian Guide Peptides & Decompression Therapy at

Common research protocols frequently investigate: 2.3mg once daily (10 units) 5 days weekly with 2 rest days More intensive protocols may investigate 2.3mg twice daily in advanced research settings Because Glow Blend contains GHK-Cu, many research protocols commonly include: Daily zinc supplementation Daily vitamin C supplementation to support collagen-related, antioxidant-support, skin-integrity, and regenerative research pathways while helping maintain copper and zinc balance in some research settings

A clinical trial for ALLO is ongoing

and for connected purposes

But heres where we need to separate enthusiasm from evidence